Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,708,362 papers from all fields of science
Search
Sign In
Create Free Account
Effexor
Known as:
Efexor
, Trevilor
, Vandral
a kind of depression treatment drug
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
24 HR venlafaxine 150 MG Extended Release Oral Capsule [Effexor]
Desvenlafaxine
Broader (2)
Venlafaxine hydrochloride
venlafaxine
Narrower (1)
Wy 45030
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Formulation of controlled porosity osmotic pump tablets containing venlafaxine hydrochloride
V. Nguyen
,
H. V. Phan
,
T. Vu
,
Cao Son Doan
2019
Corpus ID: 155531579
Venlafaxine hydrochloride is an antidepressant agents, it has a short biological half-life (5 h) thereby requiring twice a day…
Expand
Review
2019
Review
2019
Medicolegal Review: Perinatal Effexor Lawsuits and Legal Strategies Adverse to Prescribing Obstetric Providers
N. Kirsch
,
L. Pacheco
,
A. Hossain
,
J. Phelps
American Journal of Perinatology Reports
2019
Corpus ID: 108600499
Abstract Objectives This study was aimed to familiarize obstetricians with the legal environment surrounding Effexor lawsuits and…
Expand
2015
2015
Physiological and ethological effects of antidepressants: a study using ants as biological models.
M. Tricot
,
D. Cammaerts
2015
Corpus ID: 54699110
After having shown that fluoxetine, the active substance of the ISRS antidepressants, has severe adverse effects, we examined the…
Expand
2014
2014
The Comparison of Brand-Name and Generic Formulations of Venlafaxine: A Therapeutic Drug Monitoring Analysis
S. Unterecker
,
F. Proft
,
P. Riederer
,
M. Lauer
,
J. Deckert
,
B. Pfuhlmann
Therapeutic Drug Monitoring
2014
Corpus ID: 22068581
Objective: Venlafaxine (VEN) is a widely used antidepressant drug, which is available in both brand-name and generic formulations…
Expand
2011
2011
Compromising the medical literature: the hidden influence of industry-biased articles.
A. Fugh-Berman
,
J. Siwek
American Family Physician
2011
Corpus ID: 283184
Stealth marketing via journals threatens evidence-based practice, but eliminating ghostwriting does not guarantee the absence of…
Expand
2010
2010
Generic medicines literacy — minimising the potential for patient confusion
L. Graudins
,
M. Dooley
Medical Journal of Australia
2010
Corpus ID: 39405326
TO THE EDITOR: Prescribing and dispensing generic medicines is an option to reduce costs in the community and is also common…
Expand
2009
2009
Automated determination of venlafaxine in human plasma by on-line SPE-LC-MS/MS. Application to a bioequivalence study.
E. Suenaga
,
D. Ifa
,
+4 authors
C. Nakaie
Journal of Separation Science
2009
Corpus ID: 25747257
A new automated SPE-LC-ESI-MS/MS method was developed and validated to quantify venlafaxine in human plasma using fluoxetine as…
Expand
2006
2006
Neonatal seizures from in utero venlafaxine exposure
Ravi K Pakalapati
,
S. Bolisetty
,
M. Austin
,
J. Oei
Journal of Paediatrics and Child Health
2006
Corpus ID: 13538417
Abstract: Venlafaxine (Efexor), a selective noradrenergic reuptake inhibitor, is an important therapeutic option in the…
Expand
Review
2004
Review
2004
Treatments for generalized anxiety disorder
L. Struzik
,
M. Vermani
,
A. Coonerty-Femiano
,
M. Katzman
Expert Review of Neurotherapeutics
2004
Corpus ID: 12716583
Generalized anxiety disorder is characterized by excessive chronic anxiety in association with many somatic symptoms. The…
Expand
1998
1998
[Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
M. Ansseau
Revue Medicale de Liege
1998
Corpus ID: 20055480
Venlafaxine (Efexor) is the first representative of a new class of antidepressants: serotonin noradrenaline reuptake inhibitors…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE